Elmira M. Yergaliyeva

Dr. Elmira M. Yergaliyeva

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Assem Bakitzhanovna UzakovaAssem Bakitzhanovna Uzakova
Assem Bakitzhanovna Uzakova
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
Azamat YerlanulyAzamat Yerlanuly
Azamat Yerlanuly
Zhazira MukatayevaZhazira Mukatayeva
Zhazira Mukatayeva
Background/Objectives: Advanced drug delivery systems (DDSs) are essential for targeted delivery, controlled release, and reduced systemic toxicity, but their clinical adoption is limited by biological barriers, manufacturing complexities, and cost. The aim of this systematic review is to critically evaluate the quantitative relationships between platform design, overcoming biological barriers, and clinical translation outcomes for DDS developed between 2016 and 2025. Methods: A comprehensive literature search was conducted in PubMed/MEDLINE, Scopus, and Web of Science (January 2016–April 2025) in accordance with the PRISMA 2020 guidelines. Included studies focused on experimental or clinical data for nanocarrier platforms (liposomes, lipid nanoparticles, polymer systems, biomimetic carriers, extracellular vesicles). Data on platform characteristics, interactions with barriers, pharmacokinetics, manufacturing, and clinical outcomes were extracted and synthesized in narrative form due to the significant methodological heterogeneity. Results: An analysis of 77 included studies confirms that successful clinical translation depends on matching the physicochemical properties of the carrier (size, surface chemistry, material) to specific biological barriers. Liposomes and lipid nanoparticles (LNPs) remain the most clinically validated platforms, exploiting the EPR effect and liver tropism, respectively. Key engineering solutions include stealth coatings, ligand-mediated targeting, and stimulus-responsive materials to overcome barriers such as mononuclear phagocyte system clearance, the blood–brain barrier, and mucosal barriers. Microfluidic and continuous manufacturing processes enable reproducibility, but scalability, cost, and immunogenicity (e.g., anti-PEG responses) remain key translational challenges. Engineered extracellular vesicles, biomimetic carriers, and 3D/4D-printed systems combined with AI-driven design demonstrate the potential for personalized, adaptive delivery. Conclusions: Cutting-edge DDSs have validated their clinical value, but realizing their full potential requires a holistic, patient-centered design approach integrating barrier-specific engineering, scalable manufacturing, and rigorous safety assessment from the earliest stages of development. Further progress will depend on standardizing methods for new platforms (e.g., extracellular vesicles), implementing digital and AI tools, and ensuring translational feasibility as a fundamental principle.

28 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LKLyudmila Kayukova
Lyudmila Kayukova
AVAnna V. Vologzhanina
Anna V. Vologzhanina
PDPavel Dorovatovskii
Pavel Dorovatovskii
GBGulnur Baitursynova
Gulnur Baitursynova
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
KAKydyrmolla Akatan
Kydyrmolla Akatan
Nitrobenzenesulfochlorination of β-aminopropioamidoximes leads to a set of products depending on the structure of the initial interacting substances and reaction conditions. Amidoximes, functionalized at the terminal C atom with six-membered N-heterocycles (piperidine, morpholine, thiomorpholine and phenylpiperazine), as a result of the spontaneous intramolecular heterocyclization of the intermediate reaction product of an SN2 substitution of a hydrogen atom in the oxime group of the amidoxime fragment by a nitrobenzenesulfonyl group, produce spiropyrazolinium ortho- or para-nitrobenzenesulfonates. An exception is ortho-nitrobenzenesulfochlorination of β-(thiomorpholin-1-yl)propioamidoxime, which is regioselective at room temperature, producing two spiropyrazolinium salts (ortho-nitrobezenesulfonate and chloride), and regiospecific at the boiling point of the solvent, when only chloride is formed. The para-Nitrobezenesulfochlorination of β-(benzimidazol-1-yl)propioamidoxime, due to the reduced nucleophilicity of the aromatic β-amine nitrogen atom, is regiospecific at both temperatures, and produces the O-para-nitrobenzenesulfochlorination product. The antidiabetic screening of the new nitrobezenesulfochlorination amidoximes found promising samples with in vitro α-glucosidase activity higher than the reference drug acarbose. 1H-NMR spectroscopy and X-ray analysis revealed the slow inversion of six-membered heterocycles, and experimentally confirmed the presence of an unfavorable stereoisomer with an axial N–N bond in the pyrazolinium heterocycle.

3 December 2022 in Chemical Bulletin of Kazakh National University
Verified
Journal Article
Open access
PDF file
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
KBKulzada B. Bazhykova
Kulzada B. Bazhykova
SASantanat B. Abeuova
Santanat B. Abeuova
VVVladimir V. Vazhev
Vladimir V. Vazhev
PLPeter Langer
Peter Langer
This paper presents the results of predicting drug-likeness, biological activity, and toxicity for 8 new derivatives of 3,5-bis(hydroxymethyl)tetrahydro-4H-pyran-4-one using bioinformatic methods. The physicochemical and pharmacokinetic parameters of the studied compounds were determined, in silico screening for biological activity and prediction of their toxicity were carried out. Physicochemical and pharmacokinetic parameters were evaluated using the Molinspiration Cheminformatics service. It was found that compounds 1–11 corresponded to Lipinski’s rule for drug-like compounds. As predicted in Molinspiration, compound 4 exhibits significant biological activity as a possible enzyme inhibitor and G-protein coupled receptor ligand. Compound 6 is active as an ion channel modulator. Virtual PASS screening identified compounds with potential antidiabetic activity (1–3, 5–8) and activity in the treatment of phobic disorders and dementias (1–5, 7, 8, 11). Compound 1 can potentially act as a substrate for CYP2H, and inhibitors of enzymes of the peptidase group are 1, 3, 4, 6, 7, 11. As a result of QSAR prediction based on LD50 values calculated in ProTox-II, compound 10 belongs to class 6; compounds 1–3, 5 and 8 belong to the 5th class of toxicity; compounds 6 and 9 belong to the 4th class. Compound 4 belongs to class 3. Compounds 1–9 do not exhibit the toxicities shown in the ProTox-II models. Compounds 10 and 11 may be carcinogenic.

24 December 2021 in Journal of Structural Chemistry
Verified
Journal Article
Closed access
PDF file
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
LKL. A. Kayukova
L. A. Kayukova
KBK. B. Bazhykova
K. B. Bazhykova
MGM. A. Gubenko
M. A. Gubenko
PLP. Langer
P. Langer
Arylsulfochlorination of β-aminopropioamidoximes is theoretically studied using estimations of thermodynamic parameters of the corresponding reactions, quantum chemical HOMO–LUMO analysis of molecular structures of reaction products. Full geometry optimization of the molecules is performed and vibrational frequencies are calculated with the Gaussian09 program using the DFT method at the B3LYP/6-31++G(d,p) level of theory. It is established that para-toluenesulfonates and para-nitrobenzenesulfonates of spiropyrazolinium compounds are thermodynamically most preferable in the arylsulfochlorination reactions of four studied β-aminopropioamidoximes in the presence of DIPEA, while the O-substitution products are most preferable in the reaction of β-(benzimidazol-1-yl)propioamidoxime arylsulfochlorination. The calculated results agree with experimental data and can be used to predict the structure and properties of amidoxime arylsulfochlorination products.

1 January 2025 in 3i: intellect, idea, innovation - интеллект, идея, инновация
Verified
Journal Article
Open access
PDF file
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
AKAizat Khamit
Aizat Khamit
GZGuldana Zakiriyanova
Guldana Zakiriyanova
ZKZhaina Kolbayeva
Zhaina Kolbayeva
In the modern conditions of development of pharmaceutical chemistry and computer modeling, the most important task is to assess the pharmacokinetic and toxicological properties of chemical compounds at the early stages of their development. This article discusses the use of the ADMETlab-3.0 tool in the educational process of bachelor's and master's chemistry students to predict the key ADME parameters (absorption, distribution, metabolism, excretion) and toxicity of potential drug molecules. The aim of the study is to analyze the effectiveness of using ADMETlab-3.0 in teaching bachelor's and master's students, as well as to assess its role in the formation of practical skills in working with computer modeling tools. The objectives include developing a practical guide for students on the use of the platform, testing its capabilities and analyzing the impact on the educational process. Research methods include computer modeling, analysis of predicted ADME/Tox parameters, student surveys and studying their satisfaction with training. A step-by-step guide to working with the platform, sample tasks, and recommendations for integrating ADMETlab-3.0 into educational programs are presented. The results showed that the use of ADMETlab-3.0 contributes to the development of analytical skills, data interpretation, and critical thinking in students. The questionnaire confirmed a high level of satisfaction, but revealed the need for additional structured materials. The theoretical significance of the study lies in demonstrating the capabilities of digital tools in education, and the practical significance lies in developing a methodology for integrating them into the educational process. ADMETlab-3.0 is a powerful tool that simplifies the assessment of the pharmacokinetic properties of compounds and facilitates the training of specialists in the field of computational chemistry.

28 December 2018 in Chemical Bulletin of Kazakh National University
Verified
Journal Article
Open access
PDF file
KBKulzada B. Bazhykova
Kulzada B. Bazhykova
PLPeter Langer
Peter Langer
EYElmira M. Yergaliyeva
Elmira M. Yergaliyeva
TSTulegen M. Seylkhanov
Tulegen M. Seylkhanov
ZAZharylkasyn A. Abilov
Zharylkasyn A. Abilov
3,5-bis(hydroxymethyl)tetrahydro-4H-pyran-4-one by condensation of acetone with formaldehyde in the ratio of 1:4 in an alkaline medium at a temperature of 30-35°С (product yield 67.4%) was obtained. To determine the composition of obtained compound elemental analysis was used. Functional composition and structural elements were identified using IR spectroscopy. To prove the structure of the synthesized compound, 1H and 13C NMR spectra were taken on a JNN-ECA Jeol 400 spectrometer (at a frequency of 399.78 MHz and 100.53 MHz) with a CDCl3 solvent. Quantum-chemical calculations of stable conformations of 3,5-bis(hydroxymethyl)tetrahydro-4H-pyran-4-one was performed using ab initio DFT B3LYP method and 6-31G (d) and 6-311+G(3df,2p) basis sets. It was found that the stable conformers obtained by calculations are in the "chair" conformation; the hydroxymethyl substituents in conformer I are located equatorially, in conformation II – axially and equatorially, in conformation III – axially. In the conformer III, as a result of spatial proximity, hydroxymethyl substituents form an intramolecular hydrogen bond. The total energies and dipole moments were calculated; a lower value of the dipole moment of the conformation II may indicate its preference over the others.